Our Pipeline

Disease models built from patient-derived cells and 3D co-culture

Rheumatoid arthritis synovium

Using patient-derived synovial cells on PCL scaffolds, we built a 3D model of synovial hyperplasia and used it to screen disease-modifying anti-rheumatic drugs. The same model was used to test ROS-responsive anti-inflammatory nanoparticles.

Materials Today Bio (2024) · Small (2025)

3D synovial model and drug testing workflow
3D spheroids, brightfield

Tri-culture and cancer models

We developed a tri-culture platform on nanofibrous hydrogels (Biofabrication, 2025), which also underpins our retinal co-culture design.

Metastatic cancers such as breast cancer are hard to model in 2D. We are developing a system that predicts anticancer drug sensitivity using organoids derived from patient tissue.

Cell lines tested in Port Pocket culture

Five cell lines cultured for 14 days under the same conditions (5,000 cells per 20 µL dot).

Cell lineObservationBest readout window
Clone 1-5c-4Slow growth, tends to aggregateDay 10–14
MDCKFast growth, many spreading cellsDay 10–14
Hep3BVery slow growth—
A549-GFPModerate growth, no aggregationDay 14+
RPECells died during culture; conditions being revised—

Contact AiderBio

We welcome research collaborations, PoC studies, OrganoKit sample requests and partnership inquiries from pharma, CROs, hospitals and academic labs.

qaz8949@aiderbio.com